CureVac N.V. Reports Shareholder Vote Results
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | Jun 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, disclosure
Related Tickers: CVAC
TL;DR
CureVac (CVAC) filed 6-K on 6/26 showing shareholder vote results.
AI Summary
On June 26, 2025, CureVac N.V. filed a Form 6-K to report the results of votes cast at a company meeting. The filing includes a table detailing the tabulations of these votes.
Why It Matters
This filing provides transparency on shareholder decisions and corporate governance actions taken by CureVac N.V.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of shareholder vote results and does not introduce new financial or operational risks.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- 001-39446 (other) — Commission File Number
- June 26, 2025 (date) — Filing Date
FAQ
What type of information is being disclosed in this Form 6-K?
This Form 6-K discloses the results of votes cast at a company meeting, presented in a table of tabulations.
When was this filing submitted to the SEC?
The filing was submitted on June 26, 2025.
What is the Commission File Number for CureVac N.V.?
The Commission File Number for CureVac N.V. is 001-39446.
What is the principal executive office address of CureVac N.V.?
The principal executive office is located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
Is CureVac N.V. required to file annual reports under Form 20-F or Form 40-F?
CureVac N.V. indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 26, 2025 regarding CureVac N.V..